Primary HIV-1 drug resistance in spain before and after the introduction of protease inhibitors

Journal of Medical Virology

Volumn 63, Issue 2, 2001, Pages 85-87

  Prez Olmeda, Mayte ^a   Romero, Jorge Del ^b   Rubio, Amalia ^c   Ruiz, Lidia ^d   Rodrguez, Carmen ^b   Leal, Manuel ^c   Clotet, Bonaventura ^d   Soriano, Vincent ^a,e  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CENTRO SANITARIO SANDOVAL   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e Calle Rafael Calvo 7 2 A ^*  (Spain)

Author keywords

Antiretroviral drugs; Drug resistance; Epidemiology; HIV; Transmission

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; PROTEINASE INHIBITOR; ZIDOVUDINE;

ADULT; ARTICLE; BLOOD SAMPLING; DRUG EFFECT; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEROCONVERSION; SPAIN; VIRUS RESISTANCE; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; CODON; DRUG RESISTANCE, MICROBIAL; GENOTYPE; HIV PROTEASE INHIBITORS; HIV SEROPOSITIVITY; HIV-1; HUMANS; LAMIVUDINE; MUTATION; POLYMORPHISM, GENETIC; PREVALENCE; REVERSE TRANSCRIPTASE INHIBITORS; SPAIN; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035125925     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(20000201)63:2<85::AID-JMV1000>3.0.CO;2-M     Document Type: Article

References (23)

1. HIV-1 drug resistance in newly infected individuals
2. Rapid and simple method for purification of nucleic acids
3. Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy
4. Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconverters
5. Drug resistance genotyping in HIV-1 therapy: The VIRADAPT randomized trial
6. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain
7. Sexual transmission of an HIV-1 variant to multiple reverse transcriptase and protease inhibitors
8. Transmission of HIV type 1 resistant to nevirapine and zidovudine: Sydney Primary HIV Infection Study Group
9. Clinical resistance patterns and response to 2 sequential protease inhibitor regimens in saquinavir and RT inhibitor-experienced persons
10. Spanish Consensus Conference on drug resistance testing in clinical practice
11. Reduced antiretroviral drug susceptibility among patients with primary HIV infection
12. Impact of drug resistance mutations on virologic response to salvage therapy
13. HIV viral load values before and after the introduction of protease inhibitors
14. HIV-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudine
15. Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: Phenotypic resistance to protease inhibitors predicts outcome of therapy
16. Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain
17. Introduction of HIV drug resistance testing in clinical practice
18. Prevalence of HIV-1 resistance to anti-retroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use
19. Multiple dideoxynucleoside analogue resistant HIV-1 strains isolated from patients from different European countries
20. Line probe assay for rapid detection of drug selected mutations in the HIV-1 RT gene
21. Multiple drug resistance genotype causing failure of antiretroviral treatment in an HIV-infected patient heavily exposed to nucleoside analogues
22. High frequency of antiretroviral drug resistance in HIV-1 from recently infected therapy naive individuals
23. Transmission of antiretroviral drug-resistant HIV-1 variants